Genmab
GMAB
$27.46
Share price
-3.55%
Change (1 day)
-33.20%
Change (1 year)
Categories
Genmab (GMAB) - Cash on Hand
Cash on Hand as of December 2023 : $4.16 B
According to Genmab's latest financial reports the company has $4.16 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Genmab - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $4.16 B | 29.61% |
| 2022-12-31 | $3.21 B | 9.19% |
| 2021-12-31 | $2.94 B | 10.77% |
| 2020-12-31 | $2.65 B | 61.58% |
| 2019-12-31 | $1.64 B | 75.83% |
| 2018-12-31 | $0.93 B | 7.01% |
| 2017-12-31 | $0.87 B | 57.43% |
| 2016-12-31 | $0.55 B | 8.47% |
| 2015-12-31 | $0.51 B | 17.81% |
| 2014-12-31 | $0.43 B | 50.74% |
| 2013-12-31 | $0.28 B | 8.11% |
| 2012-12-31 | $0.26 B | 39.06% |
| 2011-12-31 | $0.19 B | -34.86% |
| 2010-12-31 | $0.29 B | 19.59% |
| 2009-12-31 | $0.24 B | -25.61% |
| 2008-12-31 | $0.33 B | 1183.24% |
| 2007-12-31 | $25.78 M | -91.57% |
| 2006-12-31 | $0.30 B | 54.12% |
| 2005-12-31 | $0.19 B | 159.73% |
| 2004-12-31 | $76.37 M | 46.19% |
| 2003-12-31 | $52.24 M | 44.6% |
| 2002-12-31 | $36.13 M |